Latest news from ISOLPHARM
Imaging of a Ag-111-filled phantom with clinical SPECT
In February 2026, the ISOLPHARM collaboration acquired, for the first time, a SPECT/CT image of 111Ag using a clinical system. The radionuclide was produced at LENA nuclear reactor in Pavia,[…]
Read more
ISOLPHARM 2025 annual meeting
On December 18th, the ISOLPHARM 2025 annual meeting took place at the Legnaro National Laboratories of INFN. The Work Packages of the SPES_MED, ADMIRAL and ISOLPHARM_CORE experiments showed their latest[…]
Read more
ISOLPHARM at SMRD2: the future of theragnostics
The European Federation of the Organizations of Medical Physics (EFOMP), through its Special Interest Group For Radionuclide Internal Dosimetry (SIG_FRID), after the great success of the 1st edition in 2023,[…]
Read moreA Large Collaboration Between Universities and Research Centers
The ISOLPHARM Project was born from the collaboration between the Departments of Pharmaceutical and Pharmacological, Department of Chemical Sciences of the University of Padova and the Legnaro National Laboratories (LNL) of the National Institute of Nuclear Physics (INFN) where the Selective Production of Exotic Specie (SPES) project in under development. By means, of Isotope Separation On-Line technique both traditional and innovative radioisotopes will be produced with high-specific activity, going beyond the state-of-art of the radioisotope production.
Read more
Strengths and key features
The key features of ISOLPHARM are: a) the presence of a strong local collaboration between INFN-LNL, INFN-PD, INFN-PV, TIFPA, UNIPD and UNIBS in many fields of research, ranging from the production of the RIBs to the employment of the radionuclides. b) the ISOL technique, which can easily provide high specific activity radionuclides. c) the INFN patent, which proves the innovation and excellence of the project. d) the low environmental and social impact, since nuclear reactors are not used for the provision of the radionuclides, which traditionally may be obtained irradiating massive amount of materials, that lately become tons of nuclear wastes.
Advantages
VERSATILITY
Production of a large set of radionuclides carrier-free and with large radionuclide purity
INNOVATIVITY
Many unconventional radioisotopes (short T 1/2) difficult to produce with traditional techniques
FLEXIBILITY
On-line mass selection by tuning the separator; easy production of different radionuclides
GREEN
Low production of radioative waste material